Event agenda
Tuesday, 15 October 2024
08:30 - 09:30
Registration and Coffee
09:30 - 09:40
Welcome by BioWin and Medvia
Welcome and introduction by Sylvie Ponchaut, Managing Director, BioWin and Isabelle François, Director Innovation & Strategy, MEDVIA
2 speakers
09:45 - 10:15
Plenary 1- Realising the potential of Belgium’s exceptional advanced therapy ecosystem
Pieter Sauwens, Director, Monitor Deloitte
10:00 - 16:30
Meeting block
- Baroque
Meeting duration:20 minute time slots
10:15 - 10:45
Plenary 2 - Technological diversity and excellence in advanced therapy in Flanders and Wallonia
Discussing initiatives undertaken by Belgium in the field of ATMPs, both in Flanders and Wallonia. This will include collaborations, partnerships, and strategic plans for growth.
2 speakers
10:45 - 11:15
Fireside chat - ATMP Sweden and CGT Catapult: Experience of established European ATMP Hubs and potential for collaboration
Discussing initiatives undertaken abroad in the field of ATMPs: focus on Sweden and United Kingdom.
2 speakers
11:15 - 11:40
Coffee break
11:40 - 12:30
12:30 - 13:00
Plenary 3 – Funding Opportunity for transregional R&D Projects – Focus on ATMP Research
This session will focus on funding opportunities available for research and development in advanced therapies, including grants, subsidies, BEL-COO tool and BioWin-MEDVIA joint calls.
3 speakers
13:00 - 14:15
Networking lunch
14:15 - 15:30
Pitching sessions 1 - CGT developers: pitch your business to potential partners
Providing a platform for developers of therapies (such as cell and gene therapies) and service providers looking to to develop new offering in advanced therapies research, to pitch their innovations, capabilities, and services.
15:30 - 17:00
Pitching sessions 2 - CGT service providers: pitch your business to potential partners
Providing a platform for developers of therapies (such as cell and gene therapies) and service providers looking to to develop new offering in advanced therapies research, to pitch their innovations, capabilities, and services.
17:00 - 17:10
Closing plenary by Xavier Hormaechea, President, BioWin
17:10 - 18:00